HowShorted

How shorted is Forte Biosciences, Inc.?

More shorted than 90% of the 2,877 ranked US companies

13.72%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
−1.12
5 reports (~10 weeks)
+5.04
Aggregate net short position time series for Forte Biosciences, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202613.72%−1.12
15 Jul 202614.84%+1.22
30 Jun 202613.62%+3.10
15 Jun 202610.52%+0.67
29 May 20269.85%+1.17
15 May 20268.68%+1.21
30 Apr 20267.47%+1.39
15 Apr 20266.08%−0.35
31 Mar 20266.43%+0.62
13 Mar 20265.81%+0.13
27 Feb 20265.68%−0.56
13 Feb 20266.24%+0.74
30 Jan 20265.50%−0.85
15 Jan 20266.35%+2.26
31 Dec 20254.09%+0.67
14 Nov 20253.42%−0.38
31 Oct 20253.80%+1.70
15 Oct 20252.10%+0.71
30 Sep 20251.39%+0.48
15 Sep 20250.91%+0.11
29 Aug 20250.80%−0.02
15 Aug 20250.82%−1.14
31 Jul 20251.96%–

Frequently asked questions

How shorted is Forte Biosciences, Inc. right now?
13.72% of Forte Biosciences, Inc.'s (FBRX) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.